Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Albumin for Hypoalbuminemia in Cirrhosis
NCT06411743Phase 2Completed
- Sponsor
- The First Hospital of Jilin University
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of recombinant human albumin in hypoalbuminemia and ascites (4 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Change from baseline in Albumin at Day 7. Started Sep 2021; status: completed.
02
Drugs
recombinant human albumin
03
Conditions
hypoalbuminemiaascites
Beyond the preview
Go deeper on NCT06411743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411743.